Biosensors in Drug Discovery and Drug Analysis

被引:17
|
作者
Aydin, Elif Burcu [1 ]
Aydin, Muhammet [1 ]
Sezginturk, Mustafa Kemal [2 ]
机构
[1] Namik Kemal Univ, Sci & Technol Res Ctr, Tekirday, Turkey
[2] Canakkale Onsekiz Mart Univ, Fac Engn, Dept Bioengn, Canakkale, Turkey
关键词
Biorecognition element; biosensors; drug analysis; drug discovery; electrochemical biosensor; optical biosensors; WALLED CARBON NANOTUBES; SIMULTANEOUS VOLTAMMETRIC DETERMINATION; SENSITIVE AMPEROMETRIC DETERMINATION; SELECTIVE ELECTROCHEMICAL SENSOR; NANOCOMPOSITE MODIFIED ELECTRODE; MOLECULARLY IMPRINTED POLYMER; MULTIPLE ANTIBIOTIC-RESIDUES; HUMAN BLOOD-SERUM; PASTE ELECTRODE; ANTICANCER DRUG;
D O I
10.2174/1573411014666180912131811
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Background: The determination of drugs in pharmaceutical formulations and human biologic fluids is important for pharmaceutical and medical sciences. Successful analysis requires low sensitivity, high selectivity and minimum interference effects. Current analytical methods can detect drugs at very low levels but these methods require long sample preparation steps, extraction prior to analysis, highly trained technical staff and high-cost instruments. Biosensors offer several advantages such as short analysis time, high sensitivity, real-time analysis, low-cost instruments, and short pretreatment steps over traditional techniques. Biosensors allow quantification not only of the active component in pharmaceutical formulations, but also the degradation products and metabolites in biological fluids. The present review gives comprehensive information on the application of biosensors for drug discovery and analysis. Moreover, this review focuses on the fabrication of these biosensors. Methods: Biosensors can be classified as the utilized bioreceptor and the signal transduction mechanism. The classification based on signal transductions includes electrochemical optical, thermal or acoustic. Electrochemical and optic transducers are mostly utilized transducers used for drug analysis. There are many biological recognition elements, such as enzymes, antibodies, cells that have been used in fabricating of biosensors. Aptamers and antibodies are the most widely used recognition elements for the screening of the drugs. Electrochemical sensors and biosensors have several advantages such as low detection limits, a wide linear response range, good stability and reproducibility. Optical biosensors have several advantages such as direct, real-time and label-free detection of many biological and chemical substances, high specificity, sensitivity, small size and low cost. Modified electrodes enhance sensitivity of the electrodes to develop a new biosensor with desired features. Chemically modified electrodes have gained attention in drug analysis owing to low background current, wide potential window range, simple surface renewal, low detection limit and low cost. Modified electrodes produced by modifying of a solid surface electrode via different materials (carbonaceous materials, metal nanoparticles, polymer, biomolecules) immobilization. Recent advances in nanotechnology offer opportunities to design and construct biosensors. Unique features of nanomaterials provide many advantages in the fabrication of biosensors. Nanomaterials have controllable chemical structures, large surface to volume ratios, functional groups on their surface. To develop protein-inorganic hybrid nanomaterials, four preparation methods have been used. These methods are immobilization, conjugation, crosslinking and self-assembly. In the present manuscript, applications of different biosensors, fabricated by using several materials, for drug analysis are reviewed. The biosensing strategies are investigated and discussed in detail. Results: Several analytical techniques such as chromatography, spectroscopy, radiometry, immunoassays and electrochemistry have been used for drug analysis and quantification. Methods based on chromatography require time-consuming procedure, long sample-preparation steps, expensive instruments and trained staff. Compared to chromatographic methods, immunoassays have simple protocols and lower cost. Electrochemical measurements have many advantages over traditional chemical analyses and give information about drug quantity, metabolic fate of drugs, and pharmacological activity. Moreover, the electroanalytical methods are useful to determine drugs sensitively and selectivity. Additionally, these methods decrease analysis cost and require low-cost instruments and simple sample pretreatment steps. Conclusion: In recent years, drug analyses are performed using traditional techniques. These techniques have a good detection limit, but they have some limitations such as long analysis time, expensive device and experienced personnel requirement. Increased demand for practical and low-cost analytical techniques biosensor has gained interest for drug determinations in medical sciences. Biosensors are unique and successful devices when compared to traditional techniques. For drug determination, different electrode modification materials and different biorecognition elements are used for biosensor construction. Several biosensor construction strategies have been developed to enhance the biosensor performance. With the considerable progress in electrode surface modification, promotes the selectivity of the biosensor, decreases the production cost and provides miniaturization. In the next years, advances in technology will provide low cost, sensitive, selective biosensors for drug analysis in drug formulations and biological samples.
引用
收藏
页码:467 / 484
页数:18
相关论文
共 50 条
  • [21] Harnessing the Versatility of Optical Biosensors for Target-Based Small-Molecule Drug Discovery
    Kaminski, Tim
    Gunnarsson, Anders
    Geschwindner, Stefan
    ACS SENSORS, 2017, 2 (01): : 10 - 15
  • [22] Yeast and drug discovery
    Hughes T.R.
    Functional & Integrative Genomics, 2002, 2 (4-5) : 199 - 211
  • [23] Cytomics and drug discovery
    Van Osta, P
    Donck, KV
    Bols, L
    Geysen, J
    CYTOMETRY PART A, 2006, 69A (03) : 117 - 118
  • [24] Ethnopharmacology and drug discovery
    Patwardhan, B
    JOURNAL OF ETHNOPHARMACOLOGY, 2005, 100 (1-2) : 50 - 52
  • [25] Pharmacology and drug discovery
    SJ ENNA
    中国药理学与毒理学杂志, 2019, (10) : 754 - 754
  • [26] Aging and drug discovery
    Bakula, Daniela
    Aliper, Alexander M.
    Mamoshina, Polina
    Petr, Michael A.
    Teklu, Amanuel
    Baur, Joseph A.
    Campisi, Judith
    Ewald, Collin Y.
    Georgievskaya, Anastasia
    Gladyshev, Vadim N.
    Kovalchuk, Olga
    Lamming, Dudley W.
    Luijsterburg, Martijn S.
    Martin-Montalvo, Alejandro
    Maudsley, Stuart
    Mkrtchyan, Garik V.
    Moskalev, Alexey
    Olshansky, S. Jay
    Ozerov, Ivan V.
    Pickett, Alexander
    Ristow, Michael
    Zhavoronkov, Alex
    Scheibye-Knudsen, Morten
    AGING-US, 2018, 10 (11): : 3079 - 3088
  • [27] Toxins and drug discovery
    Harvey, Alan L.
    TOXICON, 2014, 92 : 193 - 200
  • [28] ROLE OF COMPUTER AIDED DRUG DESIGN IN DRUG DEVELOPMENT AND DRUG DISCOVERY
    Bisht, Neema
    Singh, B. K.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2018, 9 (04): : 1405 - 1415
  • [29] Integration of target discovery, drug discovery and drug delivery: A review on computational strategies
    Duarte, Yorley
    Marquez-Miranda, Valeria
    Miossec, Matthieu J.
    Gonzalez-Nilo, Fernando
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2019, 11 (04)
  • [30] A new paradigm for drug discovery in the treatment of complex diseases: drug discovery and optimization
    Yuan, Yu
    Yu, Lulu
    Bi, Chenghao
    Huang, Liping
    Su, Buda
    Nie, Jiaxuan
    Dou, Zhiying
    Yang, Shenshen
    Li, Yubo
    CHINESE MEDICINE, 2025, 20 (01):